Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Sulfadiazine manufacturers

Filters

None products found

sulfadiazine

Tablets 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply
Manufacturer #15941
A pharmaceutical leader that deals with solid, semi-solid, and liquid dosage forms of medicine. This company is involved in manufacturing of its own as well as marketing and distribution of products manufactured by other companies as well.

Manufacturer usually replies in 8 days

pyrimethamine + sulfadiazine

Tablets 500 mg+25 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #19316
This pharmaceutical company specializes in both over-the-counter (OTC) and prescription generic drugs, offering products in the form of tablets, capsules, and liquids. Founded in 1992, they initially focused on the US market before expanding globally. They hold a significant distinction as the first Indian company to receive USFDA approvals for producing both OTC and prescription drugs for the US market. Their manufacturing facility is located in India, with a dedicated marketing and distribution center in the USA. Key therapy areas are not specified, nor are details about specific product patents or GMP certifications provided.

Manufacturer usually replies in 19 days

sulfadiazine

Tablets 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10170
A pharmaceutical manufacturer providing export-oriented development and commercial supply of pharmaceutical products across a complete range of finished dosage forms, including tablets, capsules, softgels, injectables, ointments, dry syrups, and sachet presentations. The organisation positions itself as a licensing-and-supply partner with integrated manufacturing expertise and a growing international portfolio, and it reports holding multiple regulatory approvals from major global authorities (including MHRA, TGA, ANVISA and GCC regulators) alongside WHO-GMP compliance for its manufacturing operations, supporting consistent quality and reliability of pharmaceutical products for overseas partners.

Manufacturer usually replies in 20 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.